Continuous Validation Support: 5 Signs Your Pharma Team Needs It
Your pharma team may need continuous validation support when validation work keeps arriving faster than your people can plan, execute, document, and close it. Five signs point that way: a growing workload, overlapping projects, a documentation backlog, missing technical skills, and a steady flow of changes that all need assessment.
None of these means your team is failing. Most plants ask capable engineers to cover production support, projects, and compliance at the same time. This guide explains each sign, why it matters, and one practical action you can take, whether or not you ever bring in outside help.
What Is Continuous Validation Support?
Continuous validation support is ongoing or project-based help from external validation engineers and technical specialists who work alongside your internal team. They help plan, execute, document, and coordinate qualification and validation work across the lifecycle of facilities, equipment, utilities, and systems.
What it can include
Depending on the agreed scope, support may cover validation engineering, commissioning, qualification and validation (CQV) activities, protocol and report drafting, schedule coordination, and specific technical studies such as cleanroom or thermal validation. The right level depends on project scope, internal capability, risk, workload, and the regulations that apply to your site.
In this article, “continuous validation support” refers to ongoing or recurring engineering support. It is distinct from continued process verification (CPV), which is a specific activity within the process validation lifecycle.
What it does not replace
External support does not replace your quality system, internal approvals, or accountability. EU GMP Annex 15 expects qualification and validation to be performed by suitably trained personnel following approved procedures, with appropriate quality oversight across the whole lifecycle. It also expects site personnel to confirm that protocols supplied by a third party suit internal procedures before approving them.
Your site retains responsibility for its pharmaceutical quality system, while QA and other designated personnel maintain their assigned oversight, review, and approval responsibilities. An outside team adds capacity and expertise without replacing these responsibilities.
Sign 1: Your Validation Workload Keeps Growing
The problem. Protocols wait weeks for an execution slot. Engineers move between breakdown support and planned qualification. Requalification dates bunch up with project milestones, and validation becomes the last item squeezed in before start-up.
Why it matters. Rushed validation raises the chance of errors, avoidable deviations, and incomplete evidence. Equipment generally should not be released for routine GMP use until the required qualification activities have been completed and the necessary approvals obtained in accordance with applicable requirements and site procedures. Delays can therefore affect production schedules.
What to do Map the next twelve months of validation work. Separate recurring tasks, such as periodic requalification, from one-off projects. Compare scheduled hours with available hours and mark the peaks. An occasional gap may only need project-based help. A gap that returns every quarter suggests an ongoing arrangement, which adds capacity without a long hiring cycle.
Sign 2: Several Qualification Projects Run at the Same Time
The problem. Imagine a site commissioning a new filling line, requalifying HVAC in an existing cleanroom, and qualifying a purified water loop in the same quarter. Each project needs requirements, protocols, execution, deviation handling, and review. They also compete for the same QA reviewers, calibrated instruments, and shutdown windows.
Why it matters. Problems appear in the dependencies. Equipment may be scheduled for qualification before its utilities are ready. Instruments may not be calibrated when installation qualification starts, although Annex 15 includes calibration of instrumentation in IQ. Documents from different projects can drift apart when nobody owns the whole picture.
What to do. Build one integrated schedule that shows dependencies. Name an owner for every protocol. Check that your validation master plan, or equivalent document, matches what is actually running. A dedicated coordinator or resident CQV engineer can hold this picture together.Type your paragraph here
Sign 3: Documentation and Follow-Ups Take Too Much Time
The problem. Engineers spend more time chasing signatures and open items than doing technical work. They spend hours drafting protocols, formatting raw data sheets, answering review comments, closing deviations, and routing approvals.
Why it matters. This work is part of the evidence. Annex 15 expects approved documents, predefined acceptance criteria, and failed results recorded as deviations and investigated. Late or inconsistent records can hold up release to the next qualification stage.
What to do. Standardize templates, keep a single tracker with owners and due dates, set a review turnaround target, and hold a short weekly review of open items. If volume remains too high, documentation specialists can take over drafting and follow-up while your QA team continues to review and approve.
Sign 4: Your Team Lacks Specific Technical Expertise
The problem. The planned work needs skills your team uses only occasionally or does not have. Common examples are
• Cleanroom validation: HEPA filter integrity testing, airflow and pressure checks, particle counting, and smoke studies.
• Thermal validation: heat distribution and temperature mapping of autoclaves, depyrogenation tunnels, cold rooms, and stability chambers.
• Equipment qualification: IQ, OQ, and PQ for complex equipment and utilities.
• Computerized systems: validation or assurance for systems that support GMP operations.
Why it matters. These studies need trained people and calibrated instruments. Weak study design or poor data can force repeat work.
What to do. List the skills the next twelve months require and compare them with your team. Build in-house the skills you use every week. For studies needed only occasionally, project-based specialist support may be more practical than maintaining every specialist skill and testing instrument in-house.
Sign 5: Ongoing Changes Need Extra Validation Planning
The problem. Equipment modifications, facility or utility changes, software updates, process changes, and periodic reviews all add validation responsibilities, and they often land on the same few people.
Why it matters. A change does not automatically mean revalidation. Annex 15 expects planned changes to be formally documented and assessed for their impact on the validated status. It also expects quality risk management (ICH Q9) to decide what validation, verification, or requalification is needed. Some changes need only a documented impact assessment. Even so, each assessment takes time and system knowledge, and backlogs build quietly when too few people handle them.
What to do. Triage changes early, use a standard impact-assessment template, and keep a calendar of periodic reviews. FDA's process validation guidance treats validation as a lifecycle activity rather than a one-time event, which is a useful way to plan. Engineers who work with your systems over time also build familiarity that one-off engagements rarely provide.
How to Decide Whether to Add Support
Use these questions in your next planning meeting:
1. Is next year's validation workload higher than last year's?
2. Are deadlines or periodic reviews slipping, or relying on overtime?
3. Do we have the skills and instruments the planned work needs?
4. Can we describe clearly what an external team would do and what stays with us?
5. Would a short project help or an ongoing arrangement fit better?
Treat the answer as a quality-system decision. Define scope, responsibilities, deliverables, review and approval roles, and communication before the work starts. Hiring a service provider does not by itself make a site GMP-compliant.
Where IncepBio's ValBio Fits
ValBio is IncepBio’s Continuous Compliance Partner model. Our dedicated validation, QA, engineering, and documentation professionals work as an extension of your internal teams, covering cleanroom and HVAC validation, thermal validation, equipment and utility qualification, and computerized systems.
Our teams arrive with IncepBio’s own calibrated instrument fleet, while IncepOne, our digital compliance and validation platform, centralizes live tracking of validation activities and associated documentation. It helps teams monitor progress, manage documentation and revision history, and maintain access to validation records to support audit readiness.
IncepBio offers flexible engagement models to suit different workloads and project requirements, including dedicated resources, resident engineers, project-based, remote, and hybrid support. CQV support is also available through our CQV services offering.
For a broader view of the model, read our article on the benefits of extended compliance support.
If these challenges are affecting your validation schedule, documentation, or available resources, explore ValBio or contact IncepBio to discuss your validation support requirements.
Conclusion
Needing help is not a weakness. It usually means validation, projects, changes, and documentation have grown beyond what one team can carry. A rising workload, overlapping projects, a documentation backlog, skill gaps, and constant change are the five signs that continuous validation support deserves a serious look.
Start with something practical: map your validation calendar, find the peaks and skill gaps, and decide which work stays in-house. If an outside partner makes sense, set a clear scope and approval roles. Done this way, continuous validation support strengthens your team without changing who is accountable.
Frequently Asked Questions
What is continuous validation support in pharma?
Continuous validation support can help pharmaceutical teams manage growing workloads, overlapping projects, documentation backlogs, and technical skill gaps. It is ongoing or project-based help from external validation engineers who work alongside internal teams on qualification, validation, documentation, and coordination. The scope is agreed upon per project, and the pharmaceutical company keeps responsibility for its quality system and approvals.
How do I know if my validation team is overloaded?
Look for slipping deadlines, repeated overtime, overlapping projects, growing backlogs of documents and open items, and periodic reviews that keep being postponed. Comparing scheduled validation hours with available hours over twelve months gives a clearer answer.
Does external validation support replace our QA team?
No. External engineers add capacity and technical expertise, but your quality unit keeps oversight, review, and approval.
Does every equipment or facility change require revalidation?
No. The need depends on your change control procedure and a documented, risk-based assessment. Some changes call for requalification or validation work, while others need only a documented impact assessment.
What should we define before engaging an external validation team?
Define the scope, deliverables, responsibilities, review and approval roles, documentation standards, communication routes, and engagement model. Agree on these in writing before work begins.